Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed, Diffuse Large B-cell Lymphoma”

1,002 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,002 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05253118
What this trial is testing

Relapsed or Refractory Primary Diffuse Large B-cell Lymphoma (DLBCL) of the Central Nervous System (CNS)

Who this might be right for
DLBCL
Seoul National University Hospital 28
Early research (Phase 1)Enrolling By InvitationNCT06827782
What this trial is testing

Cord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/Relapsed Central Nervous System Lymphoma

Who this might be right for
Refractory/Recurrent Central Nervous System Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University 42
Early research (Phase 1)Not Yet RecruitingNCT07478848
What this trial is testing

Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

Who this might be right for
Large B Cell LymphomaNon Hodgkin Lymphoma (NHL)Diffuse Large B Cell Lymphoma (DLBCL)+2 more
Abramson Cancer Center at Penn Medicine 14
Testing effectiveness (Phase 2)Study completedNCT00448201
What this trial is testing

Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 71
Testing effectiveness (Phase 2)Temporarily pausedNCT06761677
What this trial is testing

A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma

Who this might be right for
Relapsed or Refractory Lymphoma Including ENKL
SymBio Pharmaceuticals 43
Early research (Phase 1)Study completedNCT02992483
What this trial is testing

Phase I Study of MIK665, a Mcl-1 Inhibitor, in Patients With Refractory or Relapsed Lymphoma or Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma
Novartis Pharmaceuticals 31
Early research (Phase 1)Study completedNCT01120457
What this trial is testing

First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers

Who this might be right for
Acute Myelogenous LeukemiaDiffuse Large B-Cell LeukemiaChronic Lymphocytic Leukemia+1 more
Bristol-Myers Squibb 96
Not applicableEnded earlyNCT00813501
What this trial is testing

Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseInfection+7 more
City of Hope Medical Center 60
Testing effectiveness (Phase 2)WithdrawnNCT01415765
What this trial is testing

MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma

Who this might be right for
Lymphoma, Diffuse Large-Cell B-cellDiffuse, Large B-cell LymphomaLymphoma, Diffuse Large-Cell+1 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT03610061
What this trial is testing

A Trial of Radiotherapy and Durvalumab in DLBCL and FL

Who this might be right for
Diffuse Large B Cell LymphomaFollicular Lymphoma
Austin Health 34
Testing effectiveness (Phase 2)Study completedNCT00622388
What this trial is testing

Ofatumumab in Patients With Relapsed/Progressive Diffused Large B-Cell Lymphoma (DLBCL) Ineligible for or Relapse/Progression After Transplant

Who this might be right for
Lymphoma, Large-Cell, Diffuse
GlaxoSmithKline 81
Early research (Phase 1)Active Not RecruitingNCT04007029
What this trial is testing

Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
CD19 PositiveCD20 PositiveRecurrent Chronic Lymphocytic Leukemia+11 more
Jonsson Comprehensive Cancer Center 24
Testing effectiveness (Phase 2)WithdrawnNCT00776802
What this trial is testing

GCS-100LE in Combination With Etoposide and Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
La Jolla Pharmaceutical Company
Early research (Phase 1)Study completedNCT00003962
What this trial is testing

Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Active Not RecruitingNCT05658562
What this trial is testing

MT-2111 in Patients With Relapsed/Refractory DLBCL

Who this might be right for
Diffuse Large B-Cell Lymphoma
Tanabe Pharma Corporation 46
Testing effectiveness (Phase 2)Study completedNCT00077194
What this trial is testing

FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT00042666
What this trial is testing

Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas.

Who this might be right for
Non-Hodgkin's Lymphoma
Eli Lilly and Company 55
Testing effectiveness (Phase 2)UnknownNCT02851589
What this trial is testing

Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma

Who this might be right for
Acute Lymphocytic LeukemiaChronic Lymphocytic LeukemiaFollicular Lymphoma+3 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Not applicableStudy completedNCT05318391
What this trial is testing

Translational Study of Molecular Classification of Relapsed/Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Lymphoma, Large B-Cell, DiffuseGene Expression Profiling
Shanghai Zhongshan Hospital 324
Testing effectiveness (Phase 2)Ended earlyNCT01799889
What this trial is testing

Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Chronic Lymphocytic LeukemiaMantle Cell LymphomaDiffuse Large B-cell Lymphoma+2 more
Gilead Sciences 326
Load More Results